Position in APGE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$131,004,510
+$22,852,289 QoQ
Shares Held
987,000
-23.2% QoQ
Ownership
1.30%
of shares outstanding
% of Portfolio
6.61%
of 13F equity value
Holder Rank
#20
of 285 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Derivatives in APGE
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$108,575
PutShares
2,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. APGE ranks #2 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
3,750,000 | $132,712,500 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
This page
|
987,000 | $131,004,510 | |
| 3 | SYRE |
Spyre Therapeutics, Inc.
|
1,279,134 | $113,561,516 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
1,595,000 | $96,274,200 | |
| 5 | ERAS |
Erasca, Inc.
|
5,250,000 | $96,180,000 | |
| 6 | INSM |
INSMED Inc
|
650,000 | $69,303,000 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
185,000 | $61,936,150 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
590,000 | $56,150,300 |
All Filings in APGE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,004,510 | 987,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $108,152,221 | 1,284,926 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $93,212,214 | 1,234,926 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $46,620,214 | 1,173,426 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $108,575 | 2,500 | Put | Sole | 2025-08-13 | |
| 2025-06-30 | $30,049,173 | 691,899 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $43,008,794 | 1,151,199 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $42,207,278 | 931,728 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $39,014,990 | 664,198 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $32,907,736 | 836,283 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $39,344,579 | 592,093 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,006,378 | 537,093 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $22,260,843 | 1,045,110 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||